Home / Import refusals / SCS-1238642-4/11/3

FDA Import Refusal SCS-1238642-4/11/3 — GLAXO SMITH KLINE INC

GLAXO SMITH KLINE INC — FEI 3013794701

The FDA refused shipment SCS-1238642-4/11/3 from GLAXO SMITH KLINE INC (Canada) on May 5, 2022. The refused product falls under Drugs and Biologics — PHENYLEPHRINE HCL (ADRENERGIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 5, 2022
Country
Canada
Product Category
Drugs and Biologics
Product Code
60CDO09 PHENYLEPHRINE HCL (ADRENERGIC)
Charges
75

Other import refusals

  • 799-2883527-7/40002/1 (Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-4615061-6/10002/1 (Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-6306527-8/41/1 (Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0809054-8/11/1 (Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0531016-2/41/1 (Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources